+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028

  • PDF Icon

    Report

  • 190 Pages
  • July 2024
  • Region: Global
  • TechNavio
  • ID: 5509385
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The non-hodgkin lymphoma (NHL) therapeutics market is forecasted to grow by USD 6.95 billion during 2023-2028, accelerating at a CAGR of 9.45% during the forecast period. The report on the non-hodgkin lymphoma (NHL) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by recent approvals and strong pipeline, growing geriatric population, and special drug designations.

The non-hodgkin lymphoma (NHL) therapeutics market is segmented as below:

By Distribution Channel

  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy
  • Others

By Therapy

  • Immunotherapy
  • Targeted therapy
  • Chemotherapy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the research grants and funding as one of the prime reasons driving the non-hodgkin lymphoma (NHL) therapeutics market growth during the next few years. Also, growing awareness about cancer and increase in patient assistance programs and reimbursements will lead to sizable demand in the market.

The report on the non-hodgkin lymphoma (NHL) therapeutics market covers the following areas:

  • Non-hodgkin lymphoma (NHL) therapeutics market sizing
  • Non-hodgkin lymphoma (NHL) therapeutics market forecast
  • Non-hodgkin lymphoma (NHL) therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-hodgkin lymphoma (NHL) therapeutics market vendors that include AstraZeneca PLC, Baxter International Inc., Bayer AG, BeiGene Ltd., Biogen Inc., Bristol Myers Squibb Co., Eisai Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline PLC, Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd. Also, the non-hodgkin lymphoma (NHL) therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Therapy
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Non-Hodgkin Lymphoma (NHL) Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Non-Hodgkin Lymphoma (NHL) Therapeutics Market 2018 - 2022 ($ million)
4.2 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.3 Therapy segment analysis 2018 - 2022
Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel
6.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
6.3 Hospital pharmacy - Market size and forecast 2023-2028
Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
6.4 Retail pharmacy - Market size and forecast 2023-2028
Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
6.5 Online pharmacy - Market size and forecast 2023-2028
Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
7 Market Segmentation by Therapy
7.1 Market segments
Chart on Therapy - Market share 2023-2028 (%)
Data Table on Therapy - Market share 2023-2028 (%)
7.2 Comparison by Therapy
Chart on Comparison by Therapy
Data Table on Comparison by Therapy
7.3 Immunotherapy - Market size and forecast 2023-2028
Chart on Immunotherapy - Market size and forecast 2023-2028 ($ million)
Data Table on Immunotherapy - Market size and forecast 2023-2028 ($ million)
Chart on Immunotherapy - Year-over-year growth 2023-2028 (%)
Data Table on Immunotherapy - Year-over-year growth 2023-2028 (%)
7.4 Targeted therapy - Market size and forecast 2023-2028
Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
7.5 Chemotherapy - Market size and forecast 2023-2028
Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Therapy
Market opportunity by Therapy ($ million)
Data Table on Market opportunity by Therapy ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.4 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.5 BeiGene Ltd.
BeiGene Ltd. - Overview
BeiGene Ltd. - Business segments
BeiGene Ltd. - Key offerings
BeiGene Ltd. - Segment focus
12.6 Biogen Inc.
Biogen Inc. - Overview
Biogen Inc. - Product / Service
Biogen Inc. - Key news
Biogen Inc. - Key offerings
12.7 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.8 Eisai Co. Ltd.
Eisai Co. Ltd. - Overview
Eisai Co. Ltd. - Business segments
Eisai Co. Ltd. - Key offerings
Eisai Co. Ltd. - Segment focus
12.9 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.10 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key news
Gilead Sciences Inc. - Key offerings
12.11 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.12 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.13 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
12.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.16 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Non-Hodgkin Lymphoma (NHL) Therapeutics Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 33: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Distribution Channel
Exhibits 35: Data Table on Comparison by Distribution Channel
Exhibits 36: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 45: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 48: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 52: Market opportunity by Distribution Channel ($ million)
Exhibits 53: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 54: Chart on Therapy - Market share 2023-2028 (%)
Exhibits 55: Data Table on Therapy - Market share 2023-2028 (%)
Exhibits 56: Chart on Comparison by Therapy
Exhibits 57: Data Table on Comparison by Therapy
Exhibits 58: Chart on Immunotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Immunotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Immunotherapy - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Immunotherapy - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
Exhibits 66: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits 69: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits 70: Market opportunity by Therapy ($ million)
Exhibits 71: Data Table on Market opportunity by Therapy ($ million)
Exhibits 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 73: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 74: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 75: Chart on Geographic comparison
Exhibits 76: Data Table on Geographic comparison
Exhibits 77: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 109: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 110: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 111: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 112: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 113: Market opportunity By Geographical Landscape ($ million)
Exhibits 114: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 115: Impact of drivers and challenges in 2023 and 2028
Exhibits 116: Overview on criticality of inputs and factors of differentiation
Exhibits 117: Overview on factors of disruption
Exhibits 118: Impact of key risks on business
Exhibits 119: Companies covered
Exhibits 120: Matrix on companies position and classification
Exhibits 121: AstraZeneca Plc - Overview
Exhibits 122: AstraZeneca Plc - Product / Service
Exhibits 123: AstraZeneca Plc - Key news
Exhibits 124: AstraZeneca Plc - Key offerings
Exhibits 125: Bayer AG - Overview
Exhibits 126: Bayer AG - Business segments
Exhibits 127: Bayer AG - Key news
Exhibits 128: Bayer AG - Key offerings
Exhibits 129: Bayer AG - Segment focus
Exhibits 130: BeiGene Ltd. - Overview
Exhibits 131: BeiGene Ltd. - Business segments
Exhibits 132: BeiGene Ltd. - Key offerings
Exhibits 133: BeiGene Ltd. - Segment focus
Exhibits 134: Biogen Inc. - Overview
Exhibits 135: Biogen Inc. - Product / Service
Exhibits 136: Biogen Inc. - Key news
Exhibits 137: Biogen Inc. - Key offerings
Exhibits 138: Bristol Myers Squibb Co. - Overview
Exhibits 139: Bristol Myers Squibb Co. - Product / Service
Exhibits 140: Bristol Myers Squibb Co. - Key news
Exhibits 141: Bristol Myers Squibb Co. - Key offerings
Exhibits 142: Eisai Co. Ltd. - Overview
Exhibits 143: Eisai Co. Ltd. - Business segments
Exhibits 144: Eisai Co. Ltd. - Key offerings
Exhibits 145: Eisai Co. Ltd. - Segment focus
Exhibits 146: F. Hoffmann La Roche Ltd. - Overview
Exhibits 147: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 148: F. Hoffmann La Roche Ltd. - Key news
Exhibits 149: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 150: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 151: Gilead Sciences Inc. - Overview
Exhibits 152: Gilead Sciences Inc. - Product / Service
Exhibits 153: Gilead Sciences Inc. - Key news
Exhibits 154: Gilead Sciences Inc. - Key offerings
Exhibits 155: GlaxoSmithKline Plc - Overview
Exhibits 156: GlaxoSmithKline Plc - Business segments
Exhibits 157: GlaxoSmithKline Plc - Key news
Exhibits 158: GlaxoSmithKline Plc - Key offerings
Exhibits 159: GlaxoSmithKline Plc - Segment focus
Exhibits 160: Johnson and Johnson Services Inc. - Overview
Exhibits 161: Johnson and Johnson Services Inc. - Business segments
Exhibits 162: Johnson and Johnson Services Inc. - Key news
Exhibits 163: Johnson and Johnson Services Inc. - Key offerings
Exhibits 164: Johnson and Johnson Services Inc. - Segment focus
Exhibits 165: Merck KGaA - Overview
Exhibits 166: Merck KGaA - Business segments
Exhibits 167: Merck KGaA - Key news
Exhibits 168: Merck KGaA - Key offerings
Exhibits 169: Merck KGaA - Segment focus
Exhibits 170: Novartis AG - Overview
Exhibits 171: Novartis AG - Business segments
Exhibits 172: Novartis AG - Key news
Exhibits 173: Novartis AG - Key offerings
Exhibits 174: Novartis AG - Segment focus
Exhibits 175: Pfizer Inc. - Overview
Exhibits 176: Pfizer Inc. - Product / Service
Exhibits 177: Pfizer Inc. - Key news
Exhibits 178: Pfizer Inc. - Key offerings
Exhibits 179: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 180: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 181: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 182: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 183: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 184: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 185: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 186: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 187: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 188: Inclusions checklist
Exhibits 189: Exclusions checklist
Exhibits 190: Currency conversion rates for US$
Exhibits 191: Research methodology
Exhibits 192: Information sources
Exhibits 193: Data validation
Exhibits 194: Validation techniques employed for market sizing
Exhibits 195: Data synthesis
Exhibits 196: 360 degree market analysis
Exhibits 197: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global non-hodgkin lymphoma (NHL) therapeutics market: AstraZeneca PLC, Baxter International Inc., Bayer AG, BeiGene Ltd., Biogen Inc., Bristol Myers Squibb Co., Eisai Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline PLC, Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is research grants and funding."

According to the report, one of the major drivers for this market is the recent approvals and strong pipeline.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AstraZeneca Plc
  • Baxter International Inc.
  • Bayer AG
  • BeiGene Ltd.
  • Biogen Inc.
  • Bristol Myers Squibb Co.
  • Eisai Co. Ltd.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Services Inc.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.